Advancing the Therapeutic Pipeline in Alport Syndrome
Join the Kidney Health Initiative (KHI) for a mixer focused on the future of Alport syndrome therapies. Alport Syndrome Foundation will share updates from their December 2025 FDA campus meeting focused on ASSENT (Alport Syndrome Surrogate Endpoint Network), an international initiative with the goal of identifying surrogate endpoints that can be used in clinical trials […]